Healthcare Value Capital’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-350,000
Closed -$1.17M 29
2019
Q4
$1.17M Buy
350,000
+100,000
+40% +$318K 3.43% 12
2019
Q3
$760K Buy
+250,000
New +$703K 1.37% 17

Healthcare Value Capital's FOMX Position: Q1 2020 in Review

Healthcare Value Capital sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 350,000 shares — an estimated $1.17M sold.

Healthcare Value Capital first reported a position in FOMX in Q3 2019 and held it in 2 quarters. The position peaked at $1.17M in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Healthcare Value Capital reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Healthcare Value Capital sold 350,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $1.17M.
  • Healthcare Value Capital first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2019 and held it in 2 quarters.
  • Healthcare Value Capital's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.17M in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Healthcare Value Capital's 13F filing for Q1 2020, filed 15 May 2020.